批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/02/10 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/02/10 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/02/10 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/03/07 |
SUPPL-33(补充) |
Approval |
Labeling |
|
|
|
2013/07/26 |
SUPPL-35(补充) |
Approval |
Labeling |
|
|
|
2005/03/09 |
SUPPL-26(补充) |
Approval |
Labeling |
|
|
|
2004/05/03 |
SUPPL-25(补充) |
Approval |
Labeling |
|
|
|
2002/12/05 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2001/12/28 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2000/03/07 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1994/12/06 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/06/22 |
SUPPL-18(补充) |
Approval |
Labeling |
|
|
|
1992/08/27 |
SUPPL-17(补充) |
Approval |
Labeling |
|
|
|
1991/11/26 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/06/19 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/03/18 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
1990/09/11 |
SUPPL-14(补充) |
Approval |
Labeling |
|
|
|
1983/08/04 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:GENTAMICIN SULFATE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 40MG BASE/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
062251 |
001 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 40MG BASE/ML |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
062366 |
001 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 40MG BASE/ML |
Prescription |
No |
Yes |
AP |
1983/08/04
|
FRESENIUS KABI USA |
062420 |
002 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 40MG BASE/ML |
Prescription |
No |
No |
AP |
1983/08/15
|
HOSPIRA |
215237 |
001 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 40MG BASE/ML |
Prescription |
No |
No |
AP |
2024/01/08
|
EUGIA PHARMA |
活性成分:GENTAMICIN SULFATE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 10MG BASE/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
062251 |
002 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 10MG BASE/ML |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
062420 |
001 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 10MG BASE/ML |
Prescription |
No |
No |
AP |
1983/08/15
|
HOSPIRA |
062366 |
002 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 10MG BASE/ML |
Prescription |
No |
Yes |
AP |
1986/02/06
|
FRESENIUS KABI USA |
215236 |
001 |
ANDA |
GENTAMICIN SULFATE |
GENTAMICIN SULFATE |
INJECTABLE;INJECTION |
EQ 10MG BASE/ML |
Prescription |
No |
No |
AP |
2024/01/08
|
EUGIA PHARMA |